HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Altered expression of protein tyrosine phosphatase, non-receptor type 22 isoforms in systemic lupus erythematosus.

AbstractINTRODUCTION:
A C-to-T single nucleotide polymorphism (SNP) located at position 1858 of human protein tyrosine phosphatase, non-receptor type 22 (PTPN22) complementary DNA (cDNA) is associated with an increased risk of systemic lupus erythematosus (SLE). How the overall activity of PTPN22 is regulated and how the expression of PTPN22 differs between healthy individuals and patients with lupus are poorly understood. Our objectives were to identify novel alternatively spliced forms of PTPN22 and to examine the expression of PTPN22 isoforms in healthy donors and patients with lupus.
METHODS:
Various human PTPN22 isoforms were identified from the GenBank database or amplified directly from human T cells. The expression of these isoforms in primary T cells and macrophages was examined with real-time polymerase chain reaction. The function of the isoforms was determined with luciferase assays. Blood samples were collected from 49 subjects with SLE and 15 healthy controls. Correlation between the level of PTPN22 isoforms in peripheral blood and clinical features of SLE was examined with statistical analyses.
RESULTS:
Human PTPN22 was expressed in several isoforms, which differed in their level of expression and subcellular localization. All isoforms except one were functionally interchangeable in regulating NFAT activity. SLE patients expressed higher levels of PTPN22 than healthy individuals and the levels of PTPN22 were negatively correlated with the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SLICC-DI).
CONCLUSIONS:
The overall activity of PTPN22 is determined by the functional balance among all isoforms. The levels of PTPN22 isoforms in peripheral blood could represent a useful biomarker of SLE.
AuthorsHui-Hsin Chang, William Tseng, Jing Cui, Karen Costenbader, I-Cheng Ho
JournalArthritis research & therapy (Arthritis Res Ther) Vol. 16 Issue 1 Pg. R14 (Jan 17 2014) ISSN: 1478-6362 [Electronic] England
PMID24433447 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Biomarkers
  • Isoenzymes
  • RNA, Small Interfering
  • PTPN22 protein, human
  • Protein Tyrosine Phosphatase, Non-Receptor Type 22
Topics
  • Biomarkers (metabolism)
  • Blotting, Western
  • Female
  • Gene Expression Regulation, Enzymologic
  • Humans
  • Isoenzymes
  • Lupus Erythematosus, Systemic (enzymology, genetics)
  • Macrophages (metabolism)
  • Male
  • Middle Aged
  • Protein Tyrosine Phosphatase, Non-Receptor Type 22 (biosynthesis, genetics)
  • RNA, Small Interfering
  • Real-Time Polymerase Chain Reaction
  • T-Lymphocytes (metabolism)
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: